Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Cash from Investing Activities (2016 - 2026)

Sunshine Biopharma filings provide 10 years of Cash from Investing Activities readings, the most recent being -$50209.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 48.65% to -$50209.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$836306.0, a 57.75% increase, with the full-year FY2025 number at -$836306.0, up 57.75% from a year prior.
  • Cash from Investing Activities hit -$50209.0 in Q4 2025 for Sunshine Biopharma, up from -$118295.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $18859.0 in Q3 2023 to a low of -$14.6 million in Q4 2022.
  • Median Cash from Investing Activities over the past 4 years was -$259476.0 (2023), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Cash from Investing Activities: soared 98.16% in 2023 and later crashed 3655.86% in 2024.
  • Sunshine Biopharma's Cash from Investing Activities stood at -$14.6 million in 2022, then soared by 98.16% to -$269230.0 in 2023, then soared by 63.69% to -$97770.0 in 2024, then skyrocketed by 48.65% to -$50209.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$50209.0 (Q4 2025), -$118295.0 (Q3 2025), and -$491778.0 (Q2 2025) per Business Quant data.